Compound index

Growth Hormone Secretagogues & GHRH Analogs

Sermorelin

Late-stage human trialsHistorical FDA approvals withdrawn

Last reviewed: 2026-11-19

Class & structure

A 29-amino-acid chain.

Conceptual amino-acid chain · 29 residues in this molecule

How it’s thought to work

Activates pituitary GHRH receptors; clinical interpretation depends on the diagnostic or approved treatment context.

Molecule → target. A conceptual fit, not proof of a clinical effect.

Key sources

Targeted factual corrections checked against the sources below on November 19, 2026. This is not an exhaustive systematic review; discovery dates, exact molecular forms and current labels require separate verification.

Related compounds

  • CJC-1295

    Same target family · A 29-amino-acid chain. · Early human trials

  • Examorelin

    Same scientific class · A 6-amino-acid chain. · Early human trials

  • Ipamorelin

    Same scientific class · A 5-amino-acid chain. · Early human trials

  • Modified GRF (1–29)

    Same target family · A 29-amino-acid chain. · Cell/lab studies only

  • Pralmorelin

    Same scientific class · A 6-amino-acid chain. · Early human trials

Related glossary terms